Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study

被引:17
|
作者
Yang, Jingyi [1 ,2 ,3 ,4 ]
Zhong, Maohua [2 ,3 ,4 ,5 ]
Hong, Ke [6 ,7 ,8 ]
Yang, Qingyu [4 ,6 ,7 ,8 ]
Zhang, Ejuan [2 ,3 ,4 ]
Zhou, Dihan [2 ,3 ,4 ]
Xia, Jianbo [9 ]
Chen, Yao-Qing [10 ]
Sun, Mingbo [11 ,12 ]
Zhao, Bali [4 ,13 ]
Xiang, Jie [6 ,7 ,8 ]
Liu, Ying [7 ,8 ,14 ]
Han, Yang [4 ,6 ,7 ,8 ]
Xu, Mengxin [10 ]
Zhou, Xi [2 ,3 ,4 ,6 ,13 ]
Huang, Chaolin [6 ,7 ,8 ]
Shang, You [6 ,7 ,8 ,15 ]
Yan, Huimin [1 ,2 ,3 ,4 ,6 ,13 ]
机构
[1] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China
[2] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Joint Lab Infect Dis & Hlth, Wuhan, Peoples R China
[3] Chinese Acad Sci, Wuhan Jinyintan Hosp, Ctr Biosafety Megasci, Wuhan Inst Virol, Wuhan, Peoples R China
[4] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Ctr Biosafety Megasci, Wuhan, Peoples R China
[5] Wuhan Univ Sci & Technol, Med Coll, Inst Infect Immunol & Tumor Microenvironm, Hubei Prov Key Lab Occupat Hazard Identificat & C, Wuhan, Peoples R China
[6] Jinyintan Hosp, Ctr Translat Med, Wuhan 430023, Hubei, Peoples R China
[7] Wuhan Jinyintan Hosp, Wuhan Inst Virol, Joint Lab Infect Dis & Hlth, Wuhan, Peoples R China
[8] Wuhan Jinyintan Hosp, Wuhan, Peoples R China
[9] Huazhong Univ Sci & Technol, Maternal & Child Hlth Hosp Hubei Prov, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China
[10] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou, Peoples R China
[11] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China
[12] Peking Union Med Coll, Kunming, Yunnan, Peoples R China
[13] Univ Chinese Acad Sci, Beijing, Peoples R China
[14] Jinyintan Hosp, Off Drug Clin Trial Inst, Wuhan, Peoples R China
[15] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Crit Care Med, Wuhan, Peoples R China
关键词
COVID-19; differentiation; prolonged SARS-CoV-2 positivity; T-cell response;
D O I
10.1002/cti2.1259
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective SARS-CoV-2 has caused a worldwide pandemic of COVID-19. The existence of prolonged SARS-CoV-2 positivity (PP) has further increased the burden on the health system. Since T cells are vital for viral control, we aimed to evaluate the characteristics of T-cell responses associated with PP. Methods We established a PP cohort and two age- and sex-matched control cohorts: a regular clinical recovery (CR) cohort and a healthy donor (HD) cohort. The mean time for RNA negativity conversion in the PP cohort was markedly longer than that in the CR cohort (66.2 vs 25.3 days), while the time from illness onset to sampling was not significantly different. T-cell responses in the PP cohort were assayed, analysed and compared with those in the CR and HD cohorts by flow cytometry and ELISpot analysis of peripheral blood mononuclear cells. Results Compared with the CR cohort, the proliferation, activation and functional potential of CD8(+) and CD4(+) T cells in the PP cohort were not significantly different. However, the frequencies and counts of Teff and Tem in CD8(+) but not in CD4(+) T cells of the PP cohort were prominently lower. Moreover, a weaker SARS-CoV-2 N protein-specific IFN-gamma(+) T-cell response and a higher frequency of Tregs were detected in the PP cohort. Conclusion Suppressed CD8(+) T-cell differentiation is associated with PP and may be an indicator for the prediction of prolonged SARS-CoV-2 positivity in COVID-19 patients. The association between suppressed CD8(+) T-cell differentiation and elevated Tregs warrants studies in the future.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Long-lasting T-cell response to SARS-CoV-2 antigens after vaccination-a prospective cohort study of HCWs working with COVID-19 patients
    Krifors, Anders
    Freyhult, Elisabeth
    Teljeback, Mulki Rashid
    Wallin, Robert P. A.
    Winqvist, Ola
    Mansson, Emeli
    INFECTIOUS DISEASES, 2023, 55 (02) : 142 - 148
  • [42] Profound CD8 T-cell responses towards SARS-CoV-2 OFR1ab in COVID-19 patients.
    Gangaev, Anastasia
    Ketelaars, Steven L.
    Patiwael, Sanne
    Dopler, Anna
    Isaeva, Olga I.
    Hoefakker, Kelly
    De Biasi, Sara
    Mussini, Cristina
    Guaraldi, Giovanni
    Girardis, Massimo
    Ormeno, Cami M. P. Talavera
    Hekking, Paul J. M.
    Lardy, Neubury M.
    Toebes, Mireille
    Balderas, Robert
    Schumacher, Ton N.
    Ovaa, Huib
    Cossarizza, Andrea
    Kvistborg, Pia
    CLINICAL CANCER RESEARCH, 2020, 26 (18)
  • [43] Longitudinal T Cell Responses to a Series of Four SARS-CoV-2 Vaccine Doses or COVID-19 in Patients on TNF Inhibitors
    Orbo, Hilde
    Wolf, Asia-Sophia
    Bjorlykke, Kristin Hammersboen
    Josefsson, Sarah E.
    Solum, Guri
    Kjonstad, Ingrid Fadum
    Jyssum, Ingrid
    Christensen, Ingrid
    Tveter, Anne Therese
    Sexton, Joseph
    Kro, Grete B.
    Grodeland, Gunnveig
    Kvien, Tore
    Jahnsen, Jorgen
    Vaage, John Torgils
    Haavardsholm, Espen
    Provan, Sella
    Kared, Hassen
    Munthe, Ludvig A.
    Jorgensen, Kristin Kaasen
    Syversen, Silje Watterdal
    Mjaaland, Siri
    Goll, Guro
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 404 - 406
  • [44] LONGITUDINAL T CELL RESPONSES TO A SERIES OF FOUR SARS-COV-2 VACCINE DOSES OR COVID-19 IN PATIENTS ON TNF INHIBITORS
    Orbo, H.
    Wolf, A. S. F. M.
    Bjorlykke, K. H.
    Josefsson, S.
    Solum, G.
    Kjonstad, I. Fadum
    Jyssum, I.
    Christensen, I. E.
    Tveter, A. T.
    Sexton, J.
    Kro, G. B.
    Grodeland, G.
    Kvien, T. K.
    Jahnsen, J.
    Vaage, J. T.
    Haavardsholm, E. A.
    Provan, S. Aarrestad
    Kared, H.
    Munthe, L. A.
    Jorgensen, K. K.
    Syversen, S. W.
    Mjaaland, S.
    Goll, G. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 58 - 59
  • [45] Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19
    Forbes, Suzanne
    Davari, Maria
    Gnanasampanthan, Sahana
    Roth, Noam
    Young, Gregor
    Rajakariar, Ravindra
    Cove-Smith, Andrea
    Yaqoob, Muhammed Magdi
    Cutino-Moguel, Teresa
    Mahalingasivam, Viyaasan
    McCafferty, Kieran
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (07) : 1292 - 1297
  • [46] SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study
    Nersesjan, Vardan
    Amiri, Moshgan
    Nilsson, Anna Christine
    Wamberg, Christian
    Jensen, Veronika Vorobieva Solholm
    Petersen, Charlotte Bjerg
    Hejl, Anne-Mette
    Lebech, Anne-Mette
    Theut, Anna Marie
    Jorgensen, Charlotte Svaerke
    Blaabjerg, Morten
    Benros, Michael E.
    Kondziella, Daniel
    BRAIN COMMUNICATIONS, 2023, 5 (05)
  • [47] Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
    Du, Rong-Hui
    Liang, Li-Rong
    Yang, Cheng-Qing
    Wang, Wen
    Cao, Tan-Ze
    Li, Ming
    Guo, Guang-Yun
    Du, Juan
    Zheng, Chun-Lan
    Zhu, Qi
    Hu, Ming
    Li, Xu-Yan
    Peng, Peng
    Shi, Huan-Zhong
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
  • [48] PRESENCE OF SARS-COV-2 RNA IN THE SEMEN-COHORT STUDY OF COVID-19 POSITIVE PATIENTS
    Machado, Bruno
    Barra, Gustavo Barcelos
    Scherzer, Nickolas
    Massey, Jack
    Luz, Hemerson dos Santos
    Jacomo, Rafael Henrique
    Santa Rita, Ticiane Herinques
    Davis, Rodney
    JOURNAL OF UROLOGY, 2021, 206 : E632 - E633
  • [49] SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
    Rha, Min-Seok
    Kim, A. Reum
    Shin, Eui-Cheol
    IMMUNE NETWORK, 2021, 21 (01) : 1 - 11
  • [50] Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay
    Stieber, F.
    Allen, N.
    Carpenter, K.
    Hu, P.
    Alagna, R.
    Rao, S.
    Manissero, D.
    Howard, J.
    Nikolayevskyy, V.
    PULMONOLOGY, 2023, 29 (02): : 151 - 153